Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel.
Terao T, Kitamura W, Fujii N, Asada N, Kamoi C, Fujiwara K, Kondo K, Matsubara C, Hayashino K, Seike K, Fujiwara H, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y. Terao T, et al. Among authors: fujiwara k, fujiwara h. Transplant Cell Ther. 2023 Sep;29(9):573.e1-573.e8. doi: 10.1016/j.jtct.2023.06.018. Epub 2023 Jul 1. Transplant Cell Ther. 2023. PMID: 37394114
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma.
Hayashino K, Seike K, Fujiwara K, Kondo K, Matsubara C, Terao T, Kitamura W, Kamoi C, Fujiwara H, Asada N, Nishimori H, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Hayashino K, et al. Among authors: fujiwara k, fujiwara h. Int J Hematol. 2024 Apr;119(4):459-464. doi: 10.1007/s12185-024-03711-5. Epub 2024 Feb 13. Int J Hematol. 2024. PMID: 38349446 Free PMC article.
Exploring global barriers to optimal ovarian cancer care: thematic analysis.
Sfeir S, Allen L, Algera MD, Morton R, Farrell R, Brennan D, Driel WJV, Rijken MJ, Eiken M, Sundar SS, Coleman RL; collaborators of the Global Equality in Ovarian Cancer Care project group. Sfeir S, et al. Int J Gynecol Cancer. 2024 May 30:ijgc-2024-005449. doi: 10.1136/ijgc-2024-005449. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38821547
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.
Kawabata-Iwakawa R, Iwasa N, Satoh K, Colinge J, Shimada M, Takeuchi S, Fujiwara H, Eguchi H, Oishi T, Sugiyama T, Suzuki M, Hasegawa K, Fujiwara K, Nishiyama M. Kawabata-Iwakawa R, et al. Among authors: fujiwara k. Int J Clin Oncol. 2024 May 20. doi: 10.1007/s10147-024-02552-w. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38767719
3,439 results